No Data
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
Investigational Acasunlimab (DuoBody -PD-L1x4-1BB) in Combination With Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients With Previously Treated Metastatic Non-small Cell Lung Cancer (MNSCLC)
Genmab Completes Acquisition of ProfoundBio
6-K: Report of foreign private issuer (related to financial reporting)
Capital Increase in Genmab as a Result of Employee Warrant Exercise
No Data
No Data
